Sibiriline derivatives for use for preventing and/or treating disorders associated with cellular necroptosis. - Archive ouverte HAL
Brevet Année : 2017

Sibiriline derivatives for use for preventing and/or treating disorders associated with cellular necroptosis.

Fichier non déposé

Dates et versions

hal-01545878 , version 1 (23-06-2017)

Identifiants

  • HAL Id : hal-01545878 , version 1

Citer

Marie-Thérèse Dimanche-Boitrel, Stéphane Bach, Claire Delehouze, Yvette Mettey, Peter Goekjian, et al.. Sibiriline derivatives for use for preventing and/or treating disorders associated with cellular necroptosis.. France, Patent n° : WO/2017/064217. CO2GLYCO : Equipe de Chimie Organique 2-Glycochimie. 2017. ⟨hal-01545878⟩
110 Consultations
0 Téléchargements

Partager

More